Overview

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Phase I study of IMMH-010 in patients with advanced malignant solid tumors
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tianjin Chasesun Pharmaceutical Co., LTD